Back to Journals » Drug Design, Development and Therapy » Volume 10

miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism

Total article views   HTML views PDF downloads Totals
7,274 Dovepress* 6,355+ 1,493 7,848
PubMed Central* 919 343 1,262
Totals 7,274 1,836 9,110
*Since 24 February 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar